Dana Farber Cancer Institute IRB

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck Squamous Cell Carcinoma

Studies at this site

• Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy — Stopped early